Validated Spectrophotometric Method for Determination of Some Benzimidazole Derivatives in Pharmaceutical Formulations Using 1,2-naphthoquinone-4-sulphonate

References (38)

1. 1 Spectrophotometric Methods of Establishing Empirical Formulas of Colored Complexes in Solution [DOI]
2. 2 Comparative study of novel spectrophotometric methods manipulating ratio spectra: An application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin [DOI]
3. 3 Statistics in Analytical Chemistry [DOI]
4. 4 Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products [DOI]
5. 5 Method development and validation for the separation and determination of omeprazole enantiomers in pharmaceutical preparations by capillary electrophoresis [DOI]
6. 6 Spectrophotometric determination of dapsone in pharmaceutical products using sodium 1,2-naphthoquinone-4-sulfonic as the chromogenic reagent [DOI]
7. 7 The alternating current polarographic behavior and determination of lansoprazole and omeprazole in dosage forms and biological fluids [DOI]
8. 8 Spectrophotometric simultaneous determination of Rabeprazole Sodium and Itopride Hydrochloride in capsule dosage form [DOI]
9. 9 The Application of Mathematical Statistics to Chemical Analysis [DOI]
10. 10 The potency of substituted benzimidazoles such as E3810, omeprazole, RO 18-5364 to inhibit gastric H+,K+-ATPase is correlated with the rate of acid-activation of the inhibitor [DOI]
11. 11 Experimental design in the development of voltammetric method for the assay of omeprazole [DOI]
12. 12 Nonaqueous capillary electrophoresis for the analysis of labile pharmaceutical compounds [DOI]
13. 13 Omeprazole determination using HPLC with coulometric detection [DOI]
14. 14 High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction [DOI]
15. 15 Quantification of rabeprazole in human plasma by liquid chromatography–tandem mass spectrometry [DOI]
16. 16 Spectrophotometric study for the reaction between fluvoxamine and 1,2-naphthoquinone-4-sulphonate: Kinetic, mechanism and use for determination of fluvoxamine in its dosage forms [DOI]
17. 17 Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma [DOI]
18. 18 HPLC Analysis for Simultaneous Determination of Rabeprazole and Domperidone in Pharmaceutical Formulation [DOI]
19. 19 New Liquid Chromatographic Method for Determination of Rabeprazole Sodium in Coated Tablets [DOI]
20. 20 Spectrophotometric determination of certain benzimidazole proton pump inhibitors [DOI]
21. 21 Enantiospecific resolution of rabeprazole by liquid chromatography on amylose-derived chiral stationary phase using photo diode array and polarimetric detectors in series [DOI]
22. 22 Quantitative Analysis of Rabeprazole Sodium in Commercial Dosage Forms by Spectrophotometry [DOI]
23. 23 HPTLC Determination of Rabeprazole and Domperidone in Capsules and its Validation [DOI]
24. 24 Simultaneous Spectrophotometric Estimation of Rabeprazole Sodium and Itopride HCl [DOI]
25. 25 Spectrophotometric method for estimation of rabeprazole [DOI]
26. 26 Determination of iron(III) and copper(II) by zeroth, first and second derivative spectrophotometry with 2-thiobarbituric acid (4,6-dihydroxy-2-mercaptopyrimidine) as reagent [DOI]
27. 27 Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography [DOI]
28. 28 Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form [DOI]
29. 29 Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry [DOI]
30. 30 Development and Validation of Derivative Spectrophotometric Method for Determination of Rabeprazole Sodium in Pharmaceutical Formulation [DOI]
31. 31 High-Performance Liquid Chromatography and Thin-Layer Chromatography for the Simultaneous Quantitation of Rabeprazole and Mosapride in Pharmaceutical Products [DOI]
32. 32 Column Reversed-Phase High-Performance Liquid Chromatographic Method for Simultaneous Determination of Rabeprazole Sodium and Domperidone in Combined Tablet Dosage Form [DOI]
33. 33 High-performance thin-layer chromatographic determination of rabeprazole sodium and domperidone in combined dosage form.
34. 34 Simultaneous spectrophotometric estimation of rabeprazole sodium and itopride hydrochloride in capsule formulations [DOI]
35. 35 Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease [DOI]
36. 36 Validation of a Capillary Electrophoresis Method for Analysis of Rabeprazole Sodium in a Pharmaceutical Dosage Form [DOI]
37. 37 Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations [DOI]
38. 38 Simultaneous Estimation Of Amoxycillin Trihydrate And Rabeprazole Sodium

Cited by 10

Showing 4 of 10 known citations — external sources report more than can currently be individually listed.

Related research

• Expert Opinion on the Prescription Practice of Rabeprazole and Other Common Proton Pump Inhibitors for Patients with Gastroesophageal Reflux Disease — shares topic coverage
• Expert Opinion on the Prescription Practice of Proton Pump Inhibitor for the Treatment of Gastroesophageal Reflux Disease — shares topic coverage
• A Comparative Evaluation of Lafutidine and Rabeprazole in the Treatment of Gastritis and Peptic Ulcer: A Double-blind, Randomized Study in Indian Patients — shares topic coverage
• Anti-ulcer Mechanisms of L-lysine in Male Wistar Rats — shares topic coverage
• Upper Gastrointestinal Bleeding in the Absence of Proper pH Control in Patients Admitted to ICU — shares topic coverage